4D Path vs Gilboa Therapeutics
4D Path vs Gilboa Therapeutics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: 4D Path is on 59/100 and Gilboa Therapeutics on 43/100.
Where each one leads
4D Path
- our overall score: 59/100 against 43/100
- agent readiness: 30/100 against 22/100
- domain rating: 15/100 against 4/100
- headcount: 17 against 2
- LinkedIn following: 1,262 against 956
Gilboa Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | 4D Path | Gilboa Therapeutics |
|---|---|---|
| What it is | Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy. | Preclinical biopharma developing next-gen cancer immunotherapies using proprietary SolidT technology. |
| Category | Biotechnology, HealthTech, Artificial Intelligence, Cancer Research | Biopharmaceuticals, Immunotherapy, Cancer Treatment, Biotechnology |
| Sells toBusiness model | B2B2C | B2G |
| Offering | Platform | Hardware |
| Founded | 2016 | 2017 |
| Headquarters | Newton, USA | Tel Aviv, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | 4D Path | Gilboa Therapeutics |
|---|---|---|
| Employees | 17 | 2 |
| Headcount growthLast 12 months | Not published | -49.5% |
| Total funding | $17.4M | Not published |
| Latest round | Strategic financing | Not published |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 1,262 | 956 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | 4D Path | Gilboa Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 43/100 |
| Traction | 49/100 | 11/100 |
| Team | 70/100 | Not published |
| Search visibility | 39/100 | 54/100 |
| Quality | 68/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (30/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 15/100 | 4/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | 4D Path | Gilboa Therapeutics |
|---|---|---|
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Bootstrap | Not detected |
4D Path vs Gilboa Therapeutics: common questions
Which is better, 4D Path or Gilboa Therapeutics?
On our 0-100 score 4D Path rates higher (59/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do 4D Path and Gilboa Therapeutics compare on the numbers?
4D Path leads on our overall score (59/100 against 43/100), agent readiness (30/100 against 22/100), domain rating (15/100 against 4/100), headcount (17 against 2), LinkedIn following (1,262 against 956).
Read the full 4D Path review and pricing or the Gilboa Therapeutics review and pricing. You can also browse other 4D Path alternatives we track.